Skip to main content

Advertisement

SpringerLink
Log in

Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The aim of the present study was to determine the accuracy of yearly postoperative monitoring of serum tumor markers to either detect or rule out recurrence in colorectal cancer patients.

Methods

A total of 127 colorectal cancer patients who underwent curative surgery were enrolled. The serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels were assayed, and radiological examinations were performed routinely for 5 years after surgery or until recurrence was detected. Yearly recurrence rates (number of recurrences/number of patients assessed in a given year), sensitivities, specificities, and likelihood ratios were calculated. Post-test probabilities were calculated from these values.

Results

Recurrences tended to show almost the same frequencies in the first and second year after surgery (20 of 127 patients and 18 of 107 patients, respectively). However, the post-test probability of recurrence in patients with positive and negative serum CEA levels was significantly lower in the second year than in the first year (test positive: 40.0% and 76.0%; test negative: 9.3% and 0.5%, respectively).

Conclusions

Measuring CEA can help to identify patients likely to demonstrate recurrence with high accuracy only within the first year after surgery. Another examination, such as imaging, is therefore necessary for monitoring patients at 2 or more years after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rockall TA, McDonald PJ. Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer. Int J Colorectal Dis 1999;13:73–77.

    Article  Google Scholar 

  2. Mariani G, Carmellini M, Bonaguidi F, Benelli MA, Toni MG. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. Eur J Cancer 1980;16:1099–1103.

    PubMed  CAS  Google Scholar 

  3. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:8512–8519.

    Article  PubMed  Google Scholar 

  4. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313–5327.

    Article  PubMed  CAS  Google Scholar 

  5. Tveit KM. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol 2003;14:1006–1007.

    Article  PubMed  CAS  Google Scholar 

  6. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718–727.

    Article  PubMed  CAS  Google Scholar 

  7. Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238–243.

    Article  PubMed  CAS  Google Scholar 

  8. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res 2000;20:5195–5198.

    PubMed  CAS  Google Scholar 

  9. Filella X, Molina R, Pique JM, Garcia-Valdecasas JC, Grau JJ, Novell F, et al. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. Tumour Biol 1994;15:1–6.

    Article  PubMed  CAS  Google Scholar 

  10. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348–1360.

    Article  PubMed  CAS  Google Scholar 

  11. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624–630.

    PubMed  CAS  Google Scholar 

  12. Korner H, Soreide K, Stokkeland PJ, Soreide JA. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol 2007;14:417–423.

    Article  PubMed  Google Scholar 

  13. Bhandari M, Guyatt GH. How to appraise a diagnostic test. World J Surg 2005;29:561–566.

    Article  PubMed  Google Scholar 

  14. Wichmann MW, Lau-Werner U, Muller C, Hornung HM, Stieber P, Schildberg FW. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000;20:4953–4955.

    PubMed  CAS  Google Scholar 

  15. Fernandes LC, Kim SB, Saad SS, Matos D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J Gastroenterol 2006;12:3891–3894.

    PubMed  CAS  Google Scholar 

  16. De Salvo L, Razzetta F, Arezzo A, Tassone U, Bogliolo G, Bruzzone D, et al. Surveillance after colorectal cancer surgery. Eur J Surg Oncol 1997;23:522–525.

    PubMed  Google Scholar 

  17. Moertel CG, Schutt AJ, Go VL. Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA 1978;239:1065–1066.

    Article  PubMed  CAS  Google Scholar 

  18. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996;14:2843–2877.

    Google Scholar 

  19. Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Dis Colon Rectum 2008;11:1675–1680.

    Article  Google Scholar 

  20. Sackett DL, Strauss SE, Richardson WS. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone; 2000.

    Google Scholar 

  21. Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2007;96:487–491.

    Article  PubMed  Google Scholar 

  22. Davidson M. The interpretation of diagnostic test: a primer for physiotherapists. Aust J Physiother 2002;48:227–232.

    PubMed  Google Scholar 

  23. Welch JP, Donaldson GA. Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 1978;135:505–511.

    Article  PubMed  CAS  Google Scholar 

  24. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003;50:1362–1366.

    PubMed  Google Scholar 

  25. Moerte, CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 1993;270:943–947.

    Article  Google Scholar 

  26. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts J, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875–881.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

    Masayasu Hara, Mikinori Sato, Hiroki Takahashi, Satoru Takayama & Hiromitsu Takeyama

Authors
  1. Masayasu Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikinori Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoru Takayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiromitsu Takeyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hara, M., Sato, M., Takahashi, H. et al. Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year. Surg Today 41, 1357–1362 (2011). https://doi.org/10.1007/s00595-010-4519-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-010-4519-2

Key words

Search

Navigation